XBI241227C103000
- 0.09
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
Top U.S. Health Care Mid-cap Stocks and Their Quant Ratings
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Why Did Pfizer's Exit From the Gene Therapy Program Hit Sangamo Hard?
Trim the Mag 7 and Invest in Lower Valuation Dividend Growth Stocks – Miramar Capital
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Weekly Buzz: So far, Santa is Letting us Down
Bristol-Myers Squibb's Opdivo Qvantig Gets US FDA Approval
Looking At Amgen's Recent Unusual Options Activity
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
10 Health Care Stocks With Whale Alerts In Today's Session
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
Looking Into AbbVie's Recent Short Interest
$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today
How Is The Market Feeling About Alnylam Pharmaceuticals?
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Spotlight on Amgen: Analyzing the Surge in Options Activity
SPDR S&P Biotech ETF Declares Quarterly Distribution of $0.0027
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?